Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
Authors
Keywords
-
Journal
Therapeutics and Clinical Risk Management
Volume Volume 17, Issue -, Pages 371-387
Publisher
Informa UK Limited
Online
2021-04-28
DOI
10.2147/tcrm.s301817
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications
- (2021) Rajnish Kumar et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
- (2020) Philippe Colson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses
- (2020) Jieliang Chen MICROBES AND INFECTION
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
- (2020) Alfred H.J. Kim et al. ANNALS OF INTERNAL MEDICINE
- Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
- (2020) David N. Juurlink CANADIAN MEDICAL ASSOCIATION JOURNAL
- Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
- (2020) Sophie Perinel et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing
- (2020) Maria Garcia‐Cremades et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Covid-19 and immunomodulation in IBD
- (2020) Markus F Neurath GUT
- QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin
- (2020) Ehud Chorin et al. HEART RHYTHM
- Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?
- (2020) Sun Hee Lee et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
- (2020) Jacques Fantini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
- (2020) Zahra Sahraei et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
- (2020) Eli S. Rosenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
- (2020) Praveen Tilangi et al. LANCET INFECTIOUS DISEASES
- The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
- (2020) Ehud Chorin et al. NATURE MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Chloroquine-induced QTc prolongation in COVID-19 patients
- (2020) M. P. H. van den Broek et al. Netherlands Heart Journal
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
- (2020) Pradip Dashraath et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
- (2020) Caleb P. Skipper et al. ANNALS OF INTERNAL MEDICINE
- Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine
- (2020) Srinivasa Reddy Bonam et al. Autophagy
- A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
- (2020) Andrea Cortegiani et al. JOURNAL OF CRITICAL CARE
- Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
- (2020) Myron S. Cohen NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
- (2020) Lucy Catteau et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines
- (2020) Rajnish Kumar et al. Frontiers in Pharmacology
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review
- (2018) Domenico Plantone et al. CLINICAL DRUG INVESTIGATION
- Low statistical power in biomedical science: a review of three human research domains
- (2017) Estelle Dumas-Mallet et al. Royal Society Open Science
- Reemergence of chloroquine (CQ) analogs as multi-targeting antimalarial agents: A review
- (2015) Md. Mushtaque et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now